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The gut microbiota is critically important for development and maturation of the mucosal immune system right from 
birth till the whole life. The development of the immune system in neonates is especially important because it is not fully 
matured. However, its growth begins before birth. It depends on various factors like mode of delivery, mother’s microbiota, 
antibiotic consumption, mother’s milk, eating habits of infants and other environmental factors. Alterations in gut 
microbiota (dysbiosis) may disturb the gut homeostasis, and hamper the development of immune system. However, 
dysbiosis in infants may be averted by administration of probiotics. Mother’s milk contains various nutritive components 
along with some beneficial bacteria, probiotics (lactobacilli and bifidobacteria) which help in the development of gut 
microbiome of the infant. Probiotics, in particular, serve an important role in sustaining eubiosis in an infant's body. Any 
dysbiotic condition, particularly in infants, may be associated with a number of diseases/disorders like diarrhea, 
gastrointestinal problems, and allergic issues. Atopic dermatitis (AD) is one such common allergic problem prevalent in 
paediatrics. The probiotics serve as modulators of immune response and acts as immunobiotics. AD-related inflammation can be 
successfully managed by the intervention of probiotics. This review presents the potential of probiotics for proper development of 
infants’ immune system, and for prevention and treatment of various diseases, especially the ever-rising cases of AD. 
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Introduction 
Human gastrointestinal tract (GIT) harbours a wide 
range of microorganisms that represent a complex 
microbial ecosystem, and named as gut microbiota
1
. The 
gut microbiota includes beneficial, harmless and 
potentially harmful pathogenic microorganisms, which 
establishes an ecologically balanced interaction with the 
host, and help maintaining homeostasis
1
. The gut 
microbiota plays an instrumental role for preventing 
certain diseases/disorders and supporting overall good 
human health
2,3
. Alterations in gut microbiota 
composition (dysbiosis) may lead to aggravation and/or 
onset of certain diseases/disorders such as autoimmune 
and allergic diseases, colorectal and other cancer types, 
gastrointestinal issues, metabolic diseases, bacterial 
infections and others
4
. Dysbiosis can potentially be 
averted by the application of probiotics, i.e., 





Probiotics are defined by the World Health 
Organization as “live microorganisms, which when 
administered in adequate amounts confer a health 
benefit on the host”
3,5
. Probiotic consumption has 
been associated with a wide range of health benefits 
such as prevention/treatment of various types of 
diarrhea, allergies and atopic diseases, alleviation of 
lactose intolerance, modulation of the immune 
system, conditioning of gut microbiota and many 
more
6
. In addition, recent evidences show that 
probiotics may be beneficial for health-related issues 
like candidal vaginitis, sexually-transmitted diseases 
including AIDS, cardiovascular diseases/disorders, 
hypertension, hypercholesterolemia, diabetes, 
inflammatory diseases, and various types of 
cancers
5,7
. Most commonly used probiotics include 
Lactobacillus spp., Bifidobacterium spp., and the 
yeast Saccharomyces boulardii, however, a range  
of microbial spp., viz. Bacillus, Enterococcus, 
Escherichia, Propionibacterium, and several others 
are under intense investigation as promising probiotic 
bacterial strains
2,3,6
 (Fig. 1). 
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Probiotics though are vitally important for health 
and wellbeing of human beings of all ages, but these 
are considered more significant for infants/children 
and newborns
8
.  Infants are born with an immature 
immune system, and their GI tract is believed to be 
sterile, thus, making them more susceptible to 
distress i.e., diseases/disorders and infections. 
Recent studies, however, indicated that the fetal 
intestine might have exposure to microbes through 
swallowing of amniotic fluid. In any case, however, 
over a period of time infants build their gut 
microbiota which strengthens the GI tract barrier 
function and help evolving a stronger immune 





In recent years, evidences have established that 
intestinal gut microbiota may be considered as the 
measure of health and disease in newborns
2
. 
Generally sterile at the time of birth, the GIT of the 
infants is soon colonized by the microorganisms 
(mainly bacteria) ingested during the process of birth. 
Various factors have been proposed to affect the 
early-life development of the microbiota, including 
the composition of the maternal microbiome, mode of 
birth, antibiotic usage and, length of gestation
9
. 
Mother’s milk contains various nutritive components 
along with some beneficial bacteria (lactobacillus and 
bifidobacteria) which play a very important role in the 
development of the immune system of an infant
10
. 
During the first three months of infants’ life, the mode 
of delivery has been reported to be strongly linked 
with the diversity and colonization patterns of the gut 
microbiota
11
. Care must be made early during 
pregnancy to ensure that an individual's gut microbial 
flora is distributed evenly. Few of the mother's 
diseases can easily be passed down to the infant. If the 
mother has a vaginal delivery, beneficial bacteria like 
Lactobacillus can be passed to the newborn
12
. Babies 
born via caesarean section (CS) had higher abundance 
and diversity of the phylum Firmicute, and a 
relatively lower proportion and diversity of the phyla 
Actinobacteria and Bacteroidetes. Bifidobacterium 
spp. and Bacteroides genera appear to be substantially 
more common in vaginally delivered infants than in 
CS delivered infants at the colonization level
13
. The 
healthy gut microbiota contributes substantially to the 
growth and maturation of the immune system, 
whereas an aberrant gut reverses the same, and 
generally leads to serious gastrointestinal and other 
infections in children. Other factors such as a child's 
eating habits, lifestyle, and environment. significantly 
contribute to the healthy development of the immune 
system and gut microbiome
14
 (Fig. 2). 
 
Studies have established that probiotics’ 
consumption not only helps shaping a healthy gut 
microbial flora but confers protection against a wide 
range of diseases, disorders, ailments, metabolic 
issues, and pathogenic infections
6
. Several clinical 
trials have shown that the probiotics intervention may 
help in the treatment and prevention of various 
infectious disorders. Probiotics are generally given in 
various food supplements, and several such probiotic 
foods have been commercialized
15
. Infant nutrition 
relies heavily on fermented dairy products made with 
specifically selected lactobacilli and bifidobacteria 
strains. Acidophilus milk, bifidus milk, yoghurt, kefir, 
and other infant-feeding products have already been 
produced and proved to be safe for both healthy and 
sick babies. Breast milk inadequacy and modified 
infant formulae have prompted the development of 
fermented dairy products for infant nutrition
16
. 
Various studies are available where in the probiotics 
are investigated as a potential therapeutic tool in  
the treatment/management of various disorders in 
paediatrics. Therefore, this review focuses on the 
benefit of probiotic strains for managing or preventing 
various pediatric conditions.  
 
 




Fig. 2 — Role of probiotics in paediatrics 
 





Microbes involved during and after pregnancy 
The journey of a mother from conception through 
childbirth is an important one. Countless bacteria are 
involved in this process. The importance of these 
microorganisms and their interaction with the mother 
in the development of the fetus's immune system 
cannot be overstated. Infants born by Caesarean 
Section (CS) have different gut microbiota 
colonization patterns than those born vaginally. 
During the past two decades, CS has become 
increasingly popular around the world, and at the 
same time, more incidences of aberrant gut 
microbiota are being discovered in infants delivered 
by CS
13
. If a child is delivered vaginally, they are 
known to be exposed to microbes such as 
Lactobacillus sp
17
 which is significant since it is a key 
microbe that colonizes the gut and starts the 
microbiome infrastructure building process
18
. In 
contrast, if the infant is born via caesarean section, 
they are more likely to be exposed to bacteria such as 
Staphylococcus and other potential pathogenic spp.
19
, 
which are harmful to the gut development process. 
Other factors that influence the pattern of infant gut 
microbiota include the place of birth, maternal vaginal 
or skin microbiota, type of infant feeding, birth 
weight, gestational age at birth, hospitalization after 
birth, antibiotic consumption of mother and, prenatal 
probiotic therapy
13
. Any vaginal infection or oral 
infection, such as periodontitis, in the mother can 
damage the child during pregnancy. In the sense that 
the microbes found in periodontal plaque are also 
found in the mother's uterus, there is a clear link 
between the two. As a result, it is critical to maintain 
good dental hygiene throughout pregnancy in order to 
ensure proper microbe seeding from the mother to the 
foetus. 
It is important to ensure that the new-born is fed 
mother's milk after birth since it is high in 
Lactobacillus and Bifidobacterium spp.
20
, which 
consequently may make up to 90% of the gut 
microbiota. Lactobacillus and Bifidobacterium spp. 
constitute a substantial population of microflora, that 
is transmitted to the neonate endogenously or during 
breast feeding, which plays an important role in the 
development and maturation of the infant’s immune 
system. The probiotic bacterial species such as 
Staphylococcus, Enterococcus, Streptococcus, 
Lactobacillus, and Bifidobacterium have been isolated 
from human colostrum samples. It is pertinent to 
mention that bifidobacteria play a vital role against 
the adhesion of pathogenic bacteria to an infant gut 
during the early stages when their immune system is 
immature
21
. Moreover, the breast milk contains short-
chain fatty acids (SCFAs) generated from the 
fermentation of indigestible food, which acts as 
nutrient source (prebiotics) for the beneficial bacteria 
in the infant’s GI tract
10
. Also, the sugar in breast milk 
is a source of oligosaccharide, another prebiotic that 
significantly contributes towards development of a 
healthy gut microbiota in the infant's body. 
Antibiotics should not be taken by the mother during 
pregnancy because they promote microbial depletion, 
which is detrimental to both the mother and the baby. 
Aside from them, the gut microbiome's infrastructure 
is influenced by factors such as the environment and 
eating habits
14
. The microbiome of an adult is 
developed in the first two years of a child's existence, 
known as the "thousand-day window." This 
microbiome infrastructure is what determines an 
individual's immunological condition throughout  
their lifetime. 
 
Development of immune system in infants 
Because of the change in environment from the 
protective mother's womb to the outside environment, 
the immune system development of the infant at the 
time of birth and immediately afterward is critical. 
The immune system of the infant develops in 
conjunction with its microbiome
22
. In this sense, the 
first thousand days are critical for the establishment of 
the infant’s microbiome infrastructure, which is 
supported by the development of the infant’s immune 
system. 
A well-developed eubiotic gut with high microbial 
diversity at birth aids the development of a resilient 
and well-functioning immune system in the infant, 
and it offers a huge number of benefits throughout the 
life. There are pathogenic bacteria that are not 
mutualistic in nature even in the eubiotic gut. As a 
result, as long as these pathogenic bacteria do not 
cause infection
23
, a well-established immune system 
will be able to tolerate them to a certain level. This 
tolerance is an immune system feature that is 
influenced by microbial diversity.  
 
The immune system begins to develop in the 
womb. The placenta transfers maternal 
immunoglobulin (IgE) antibodies to the foetus in 
pregnancy. IgA is transmitted to the foetus via breast 
milk after delivery, during the first six months, while 
the infant's immune system is maturing
24
. Secretory 





IgA (sIgA) in breast milk not only protects against 
pathogens but also promotes the development of 
microbiota in the newborns
25
. The foetus receives 
immunological support from the mother not only 
while in the womb, but also during the first six 
months of pregnancy, when the infant's immune 
system is developing and maturing. Human milk 
offers the newborn with many layers of protection 
against infections, promotes stimulation  
and maturation of the immune system, intestine 
development and establishment of the healthy gut 
microbiome
2
 in addition to transmitting IgA. 
Furthermore, oligosaccharide sugars (prebiotics) 
available in human milk travel undigested into the 
infant's gastrointestinal tract and serve as nutrients to 
support the growth of good or beneficial bacteria such 
as Bifidobacterium and Lactobacillus spp. Thus, 





For the development of the immune system, 
exposure to the environment is especially vital 
throughout the infant's early years. Antibiotics, 
processed or sugary foods and certain metabolic 
abnormalities have a negative impact on the baby 
during pregnancy. The microbial colonisation of the 
gastrointestinal tract, respiratory tract and skin is 
negatively affected by these factors. During microbial 
colonization, the microorganisms release metabolites 
that influence immunological development in terms of 
the immune system's organs and cells
11
. Due to the 
transfer of lactobacilli and other beneficial bacteria 
from the mother to the child, a vaginal delivery is 
thought to be a better form of delivery during 
childbirth. All these variables contribute to the 
immune system's correct functioning, and healthy life 
at infant level and older stages of life. On the other 
hand, if the immune system is not properly formed, a 
wide range of allergies, and other serious 
diseases/disorders may be experienced.  
 
Distribution of immune components in the gut 
The gut immune system is influenced at three 
levels: (i) The gut microbiota, which consists of 
intestinal microbiota and luminal antigens; (ii) The 
single layer gut epithelial barrier with tight junctions; 
and (iii) The lamina propria which consists of gut-
associated lymphoid tissue. 
The intestinal immune system is an integral and 
potent defense system to regulate commensal 
tolerance and pathogen elimination
26
. Factors like gut-
associated lymphoid tissue and intestinal microbiota 
are influenced by each other. Immune privilege is 
developed by the presence of tight junctions and a 
eubiotic state of the gut lumen. This develops the 
‘tolerogenic state’ in the gut. During the homeostatic 
interaction between gut microflora and the immune 
system, the intestinal epithelium plays several 
protective roles, including acting as a physical barrier 
for the separation of luminal bacteria from the host 
tissue. Thereby, an accurate immune development and 
the immune response is particularly dependent on the 





Intestinal homeostasis is established through 
dynamic and delicate crosstalk between host immunity 
and the microbiome. Early infancy is critical for the 
child's intestinal homeostasis. The gut's tolerogenic 
state is maintained by a balanced connection among 
immune system components
27
, the intestinal 
microbiota, luminal antigens and, the epithelial barrier. 
As a result, colonization with beneficial flora boosts 
intestinal immunity and the development of 
immunotolerance in early childhood, resulting in a 
balanced Th1/Th2 immune response
28
. In the gut, Treg 
cells maintain homeostasis at steady-state where the 
cells play an important role in the regulation of 




On the other hand, a disruption in homeostasis may 
result in allergies and several other diseases/disorders. 
A disruption in homeostasis can alter the microbiota 
and trigger an allergic reaction, leading to atopy. 
Cow’s milk allergy (CMA) is one of the most 
common food allergies in early infancy. In particular, 
the anti-allergic effect of probiotic Lactobacillus GG 
(LGG) on cow’s milk allergy (CMA) has been 
extensively studied and shown to improve the gut 





Hygiene hypothesis and Allergy 
According to the hygiene theory, early childhood 
exposure to specific microbes protects against allergy 
disorders by aiding immune system development
30,31
. 
The disruption of a balanced microbiome can lead to 
immunological dysregulation resulting in more 
susceptibility to diseases such as inflammatory  
bowel disease (IBD), obesity and, allergic diseases 
(including asthma and food allergy) in children
32
. If 
the early childhood exposure to exogenous antigens is 





low or non-existent, it may result in poor immune 
function maturation and loss of immunological 
tolerance. Due to poor immune tolerance, the 
Th2/Th1 transition is hampered, and causes increased 
risk of allergic disorders. Dramatic growth in allergy 
disorders has been witnessed over the past 5-6 
decades (first half of the twentieth century) mainly 
due to reduced microbial exposure, increased 
antibiotic usage, and changed lifestyles. As a result, 
increased incidences of allergy illnesses are 
encountered in the second half of the twentieth 
century. Children with one atopic condition, such as 
eczema, food allergies, rhinitis or asthma, may 
acquire another atopic condition with the same trigger 
factor. These allergic reactions could eventually 
evolve to severe atopic dermatitis. An altered gut 
microbiome affects microbiota-derived products and 
metabolites, including pro and anti-inflammatory 
factors. Protection against microbial invasion is 
rendered by an intestinal barrier which has multiple 
lines of defense including commensal bacteria, which 
competitively inhibit the colonization of pathogenic 
bacteria, and also produce protective metabolites
32
.  
There is a well-established link between decreased 
microbial diversity and an increased risk of allergy 
disorders. For instance, Bifidobacterium longum,  
B. breve, and Lactobacilli plantarum were found to 
possess anti-allergic potential in both animal models 
and clinical trials
25
. Non-allergic infants have a high 
microbial diversity in the Shannon diversity index, 
but allergic infants have a low microbial diversity. 
Reduced biodiversity in the first month of infancy has 
been linked to an increased risk of eczema, allergic 





. At one week of age, fewer 
bifidobacteria and greater staphylococci and clostridia 
correlate with a higher allergy risk. Probiotics’ 
application may help in restoring healthy gut 
microbiota, and a favorable interaction between 
microbiota and host immune system despite dysbiosis. 
Furthermore, anti-allergic effects of probiotics 
coupled with their ability of strengthening the gut 
barrier function (the intestinal epithelial layer), may 





Role of gut and skin microbiome in regulating immune system 
Microbiome plays an important role in the proper 
functioning of the immune system. Some results of 
poor microbiome infrastructure include
35
: (i) Poor 
digestion/frequent diarrhoeal symptoms; (ii) Poor 
immunity development and  high susceptibility to 
infections; (iii) Antibiotic-associated dysbiosis;  
(iv) Lactose intolerance; (v) Atopic dermatitis; and 
(vi) Infantile Eczema. 
 
Not just in the gut, but also in the skin, the 
microbiome plays a key role in ‘Immune Regulation’. 
One trillion bacteria are present on the skin alone, out 
of the 100 trillion bacteria found in and on us. Skin 
microorganisms aid in the maintenance of the skin 
barrier. It aids wound healing and reduces oxidative 
damage by minimising allergen and UV radiation 
exposure.  
 
Immunomodulatory effect of the probiotic is 
associated with the release of cytokines from the 
various immune cells including macrophages, 
lymphocytes, epithelial cells, granulocytes and others. 
The mechanisms of immune system modulation by 
probiotics can be either immune-stimulatory or it can 
be immune-regulatory
36
. The probiotics which are 
immunostimulatory have the ability to induce IL-12 
production which leads to the activation of the natural 
killer cells and Th1 cells to act against various 
infections and to fight against cancer cells. Probiotics 
of this kind can also act against allergies. The 
probiotics having the immunoregulatory potential 
have the ability to induce the production of IL-10 and 
Treg cell, resulting in decreases in allergy, 
inflammatory responses, inflammatory bowel disease 
and autoimmune diseases
37
. Several effects of 
probiotic lactic acid bacteria are mediated via immune 
stimulation mainly by maintaining the balance 
between anti-inflammatory and pro-inflammatory 
cytokines. Various probiotic bacteria are known to 
down regulate the level of pro-inflammatory 
cytokines such as TNF-α, IL-6, and IL-1β, and up 
regulate the level of anti- inflammatory cytokines 
such as IL-10
38
. Dysregulation of pro-inflammatory 
and anti-inflammatory cytokines results in the 
inflammatory disorders such as obesity, diabetes and 
metabolic syndrome leading to the state of chronic 




Probiotics and Atopic Dermatitis (AD) 
Atopic dermatitis (AD) is defined by an aberrant 
skin barrier caused by several means (e.g., genetic, 
environmental and immunologic). AD may lead to the 
development of other atopic disorders such as food 
allergies, allergic rhinitis, and asthma. The atopic 
march can be triggered by epithelial dysfunction 





linked to the microbiota and immunological 
dysregulation
32
. Specific allergens sensitise AD 
patients, and the skin serves as a route for allergen 
intake. Antigens stimulate the innate response by 
inducing cytokines in the epithelium. These processes 
work together to induce Th2 cells
28
 from naive-T cells 
which then secrete IL-4, IL-5, IL-13 and IL-31 as well 
as produce IgE and activate basophils and mast cells. 
(Fig. 3) 
Among various causes of AD such as hereditary, 
epidermal barrier dysfunction, environmental, or 
immunologic, the immunological root cause is the 
most critical. Additionally, AD patients show 
increased intestinal permeability and a defective 
(“leaky”) gut barrier, enabling food allergen 
penetration and sensitization via the gut
32
. The 
immune system may be corrected with the help of a 
good site-specific, disease-specific, and strain-specific 
probiotics or with conventional medicines, the AD 
can be excellently treated/managed
40
. Exposure of 
atopic skin to a potential allergen increases the 
expression of thymic stromal lymphopoietin (TSLP), 
which is known to activate dendritic cells (DC) in the 
skin, which is the immunological cause of AD. The 
activated dendritic cell then drives the development of 
naive T cells into Th2 and Th17 cells, which are 
known as mediators of allergic inflammation and 
dermatological illnesses such as AD.  
Probiotics based therapy may potentially be applied 
for the prevention and treatment of various skin 
diseases such as eczema, atopic dermatitis, acne, and 
allergic inflammation or hypersensitivity, and 
others
41
. Because probiotics regulate skin and 
stomach homeostasis, which are interconnected, they 
can be beneficial in the treatment of various skin 
diseases including especially the AD. Probiotics are 
known to be effective for the treatment of a variety of 
skin problems
41
. In order to combat AD, probiotics 
must be immunobiotic. Oral probiotics function by 
raising the population of regulatory T cells (Tregs) in 
the mesenteric lymph nodes, which can help to reduce 
allergic inflammation. Through lymphatic drainage, 
these Tregs could migrate to the site of inflammation 
on the skin, suppressing the Th2 and Th17-mediated 
allergic response in the skin while also lowering the 
expression of TSLP. As a result, the AD-related 
inflammation is kept under control. Thus, the 
probiotics serve as modulators of immune response. 
 
Clinical trials study  
Rising prevalence of infant and childhood allergic 
diseases especially the atopic dermatitis (AD) has 
been a cause of great concern. Alterations in the gut 
microbiota and consequential changes in the immune 
system regulation have been considered as one of the 
major reasons for increasing AD incidences
42
. 
Application of probiotics has been reported to play an 
important role in prevention and treatment of  
AD
42, 43, 44, 45
. 
Several clinical studies have indicated the potential 
of probiotics for managing ever-rising cases of AD. 
Meta-analysis of clinical trials involving prenatal and 
postnatal probiotics’ application for prevention/ 
treatment of pediatric atopic dermatitis showed the 
mixed results, and a clear conclusion or interpretation 
could not be drawn
45
. Reduction in the Scoring Atopic 
Dermatitis (measurement of AD severity) by  
−6.64 and −8.56 points in the intergroup, and by 
−1.06, and −1.37 in the intragroup was not that 
convincing. Thus, the treatment trial was not 
clinically significant.  In contrast, however
43
 
established the protective effects of probiotics for the 
treatment of infantile atopic dermatitis in a meta-
analysis study of clinical trials. Double-blinded 
randomized clinical trials were examined to evaluate 
the efficacy of probiotics (Lactobacillus sp.) for the 
treatment of atopic dermatitis in infants. The overall 
pooled change in Scoring Atopic Dermatitis index 
(95% CI) was −5.71 (P < 0.01) while in subgroups it 
was −8.32. The study clearly showed the beneficial 
effects of probiotics’ application for the treatment of 
atopic dermatitis
43
. Another meta-analysis of 
randomized controlled studies revealed that the 
prenatal or postnatal application of probiotics 
(Lactobacillus alone and combined Lactobacillus with 
Bifidobacterium) provides protection against AD 
occurrence (P < 0.001). Both general and high risk 
 
 
Fig. 3 — Atopic dermatitis in paediatrics and role of probiotics 
 





population subgroups exhibited protection against AD 
development
46
. In contrast, however
47
 could not 
establish the beneficial effect of probiotic 
administration for the treatment of atopic dermatitis 
especially in infants during meta-analysis of clinical 
trials.  
Another meta-analysis of randomized clinical trials 
for prevention and treatment of atopic dermatitis in 
children by the application of mixture of probiotics 
and prebiotics (synbiotics) was executed 
42
. The 
overall pooled change in SCORAD index was −6.56 
(95% CI; P = .008), and heterogeneity was significant 
(P < 0.001). Subgroup analysis further suggested the 
significant beneficial effect of synbiotics for treating 
AD in children
42, 44
 conducted a randomized, double-
blind study (70 patients, 20 adults and 50 children) 
having moderate to severe AD. The participants were 
randomized into control arm (received only 
conventional therapy) and treatment arm (received 
conventional and probiotic therapy). SCORAD score 
analysis revealed that the score was considerably 
reduced in the case of treatment arm as compared to 
the control arm indicating the significant effect of 
probiotics application in the treatment arm.  Thus, it 
was concluded that probiotics administration 
augments the conventional AD therapy quite 
effectively (in both adults and children) under 
moderate and severe condition of the disease
44
. 
In a recent study based on a post hoc analysis of a 
clinical trial
48
 a correlation has been investigated 
between the changes in gut microbiota and response 
to probiotics treatment in AD patients. Administration 
of a mixed probiotic formulation (Bifidobacterium 
spp. and Lacticaseibacillus spp.) in children (4–17 
years) with AD showed a significant improvement in 
SCORAD (scoring atopic dermatitis) index. However, 
gut microbiota diversity changes were insignificant 
even after consumption of probiotics. Bacteroides, 
Ruminococcus, and Bifidobacterium were 
significantly increased in the probiotic group while 
the Faecalibacterium decreased as compared  
to the placebo group. The highest presence of 
Faecalibacterium was significantly positively 
correlated with AD severity (SCORAD index), 
however, Abyssivirga, Bifidobacterium, and 
Lactococcus had an inverse correlation. It was 
concluded that consumption of the probiotic 
formulation modulates the gut microbiome with 
significant changes in genera Bacteroides and 
Faecalibacterium. In turn, the improvement in 
SCORAD correlates with a decrease in 
Faecalibacterium and an increase in Bifidobacterium, 
among others. 
Different research reports though shows the 
protective effects of probiotics for the prevention and 
treatment of AD
49
, however, the positive effects are 
dependent on several factors viz. type of probiotic 
strains, administration time, exposure duration, 
dosage and other parameters. However, despite 
several studies, strong evidence to establish the role of 






The gut microbiome plays an important role in 
health and disease, and probiotics represent a 
promising modality for prophylactic and therapeutic 
interventions. In paediatrics, probiotics play a critical 
role in early immunological development. It aids the 
child in maintaining a healthy gut. A good probiotic 
boosts a child's immune system and ensures a higher 
level of wellness by protecting them from invading 
bacteria and viruses. Paediatric allergic diseases  
such as atopic dermatitis (AD) can be successfully 
managed by the intervention of probiotics. Differences 
in strain specificity, timing of administration, and length 
of the therapy are all contributing towards the beneficial 
effect of probiotics they impart to the host. However, 
further studies especially the clinical trials of the selected 
probiotic strains are necessary to establish the role of 
probiotics in modulating the allergic manifestations. 
Also the functional mechanism of probiotics in immune 
modulation, and for providing protective effects in AD 
or other diseases needs to be investigated.  
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